September 14, 2015 8:15 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
(NASDAQ: COLL) shares rose 41.26 percent to $19.00 in pre-market trading after the company reported that the FDA Advisory Committees have unanimous recommended the approval of Xtampza ER.
Aquinox Pharmaceuticals Inc (NASDAQ: AQXP) shares jumped 23.17 percent to $21.26 in pre-market trading after gaining 4.86 percent on Friday.
Geron Corporation (NASDAQ: GERN) shares rose 4.82 percent to $3.70 in pre-market trading after surging 4.44 percent on Friday.
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) gained 1.52 percent to $136.10 in pre-market trading. Analysts at Barclays upgraded Vertex Pharmaceuticals from Equal-weight to Overweight and raised the price target from $120.00 to $150.00.
Apple Inc. (NASDAQ: AAPL) shares climbed 1.22 percent to $115.60 in pre-market trading after rising 1.46 percent on Friday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.